Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

018IC - Prostate Cancer Diagnostics: Biomarkers, MRI, & Biopsy Techniques

Friday, May 18
4:00 PM - 6:00 PM
Location: MCC WEST, 2004

Course Description: This course is intended for urologists interested in optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications. The attendee will explore the continuing controversy of screening for prostate cancer, prostate cancer detection guidelines, use of PSA, PSA adjuncts and isoforms, and other biomarkers for prostate cancer detection. This will lead into a discussion of prostate biopsy, including concepts crucial to reducing morbidity of prostate biopsy and improving patient experience. This course reviews available data regarding biopsy indications and techniques as well as ideal number and location of cores. The course also covers clinical implications of pathological findings such as prostatic intraepithelial neoplasia (PIN) and atypical small acinar proliferation (ASAP), and emerging markers designed to improve cancer detection. Additionally, this course fully explores the imperative of having a purposeful approach to biopsy aimed at diagnosing clinically meaningful cancer while minimizing detection of clinically insignificant cancer. We also present the most current information regarding the use of image guided biopsy techniques, such as MRI-ultrasound fusion guided biopsy. Overall, the course provides an evidence-based and practical overview of methods to detect and diagnose prostate cancer.

Learning Objectives:

Daniel A. Barocas

Vanderbilt University Medical Center

Daniel A. Barocas, MD, MPH, FACS is Associate Professor of Urologic Oncologiy at the Vanderbilt University Medical Center, and the Vanderbilt Ingraham Cancer Center. He has clinical and research interests in urologic cancers, particularly in the detection and treatment of localized cancers, and the measurement of patient outcomes and quality of care. He is co-director of the Center for Surgical Quality and Outcomes research, an intellectual home for surgeon scientists at VUMC. Dr. Barocas has received grants from NIH to study active surveillance for prostate cancer care, and to study variation in the evaluation of hematuria. He is currently co-PI of the CEASAR study (Comparative Effectiveness Assessment of Surgery And Radiation), funded by AHRQ to study patient-reported outcomes in a large prospective, population-based cohort study. In addition to his activities as a urologic oncologist and health services researcher, Dr. Barocas is involved with national organizations, including the American Urological Association and Commission on Cancer, in development of quality measures for urologic cancer care.


Send Email for Daniel Barocas

Scott E. Eggener


Send Email for Scott Eggener

John Wei

University of Michigan

Dr. John Wei completed his Urology residency training at NYH Cornell Weill Medical Center (1997) followed by Health Services Research training in the Robert Wood Johnson Clinical Scholars Program (1999). He is a practicing surgeon and Professor of Urology at the University of Michigan. His General Urology practice focuses on male voiding problems (Benign Prostatic Hyperplasia – BPH/LUTS) and prostate cancer early detection. Administratively, he is the Associate Chair for Faculty Affairs in the Department of Urology and the Medical Director of the Livonia Center for Specialty Care. His areas of active research are on quality of care assessments, assessment of clinical outcomes, biomarker validations, and evaluation of health related quality of life.


Send Email for John Wei


018IC - Prostate Cancer Diagnostics: Biomarkers, MRI, & Biopsy Techniques


Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Prostate Cancer Diagnostics: Biomarkers, MRI, & Biopsy Techniques